Articles About Arena pharmaceuticals
-
May 04, 20131 Winner and 4 Losers from This Week’s Earnings Storm
Analysis of company earnings affecting stocks for NBIX, ARNA, CPIX, VCRA, EBS
-
May 03, 2013Sprint Opposed By Mount Kellett Alliance and 2 Other Hot Stocks To Watch
Here are the top trending stocks of the day...
-
May 03, 2013Analysts: Estimates on AIG Will Increase and 3 Other Research Notes to Browse
Here's what analysts are telling investors this morning...
-
May 02, 2013Arena Pharmaceuticals Earnings: Here’s Why Investors are Selling Shares Now
Here's your Cheat Sheet to earnings...
-
April 19, 2013Do These Factors Support Arena Pharmaceuticals?
Arena Pharmaceuticals engages in a biotechnology industry that provides promise but still needs to see results. The stock has been in a downtrend over the last few years as any reasonable pop has been met with selling pressure...
-
April 05, 20134 Healthcare Stock Stories for Weekend Perusal
Analysis of Top healthcare Business News: 4 Healthcare Stock Stories for Weekend Perusal
-
March 14, 2013Will Arena Pharmaceuticals Move Higher?
If Arena is able to create a profitable product, the company is poised to see excellent returns. Investors have been mixed about the last four earnings announcements and it shows in their relative performance...
-
March 09, 2013Did These Stocks Miss or Beat Analyst Expectations?
Analysis of company earnings affecting stocks for ARNA, SNTS, POZN, LHCG, FURX
-
March 04, 2013
Arena Pharmaceuticals Earnings: Here’s Why Shares are Down Now
Here's your Cheat Sheet to earnings...
-
March 04, 2013
Arena Pharmaceuticals Earnings: Here’s Why Shares are Down Now
Here's your Cheat Sheet to earnings...
-
January 07, 2013Will Vivus’s Weight-Loss Drug Fall Flat?
Qsymia sales only generated $41,000 in the company’s third quarter, representing 656 filled prescriptions. But on Monday, Vivus reported that sales of its main product rose close to 68 percent in the month ended December 21, which was well above analysts' expectations...
-
December 11, 2012Does Arena Pharma’s Stock Have Potential to Skyrocket?
Big bets have been placed on both sides....
-
November 20, 2012Arena Pharma Shares Pop and 3 Movers Demanding Attention
Here's why these stocks are demanding attention...
-
November 06, 2012Arena Pharma Earnings Sneak Peek
Here's what you need to know for the upcoming earnings release ...
-
November 03, 2012
Who’s Winning the Weight-Loss Drug Race?
While Vivus launched its drug Qysmia at the end of September, ahead of rivals Arena and Orexigen, the race for the most successful treatment has not yet been won...
Wall St. Cheat Sheet has been featured in these fine media outlets:
